VIMGF (Vimian Group AB) FCF Margin % : 17.83% (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Vimian Group AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Vimian Group AB's Free Cash Flow for the three months ended in Dec. 2024 was $19.6 Mil. Vimian Group AB's Revenue for the three months ended in Dec. 2024 was $109.8 Mil. Therefore, Vimian Group AB's FCF Margin % for the quarter that ended in Dec. 2024 was 17.83%.

As of today, Vimian Group AB's current FCF Yield % is 2.61%.

The historical rank and industry rank for Vimian Group AB's FCF Margin % or its related term are showing as below:

VIMGF' s FCF Margin % Range Over the Past 10 Years
Min: -28.42 Med: 1.9 Max: 11.71
Current: 11.69

During the past 8 years, the highest FCF Margin % of Vimian Group AB was 11.71%. The lowest was -28.42%. And the median was 1.90%.

VIMGF's FCF Margin % is ranked better than
76.78% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.33 vs VIMGF: 11.69

Vimian Group AB FCF Margin % Historical Data

The historical data trend for Vimian Group AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vimian Group AB FCF Margin % Chart

Vimian Group AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-1.11

2.61

5.33

-13.11

11.71

Vimian Group AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															12.73	7.99	4.25	16.03	17.83

Competitive Comparison of Vimian Group AB's FCF Margin %

For the Diagnostics & Research subindustry, Vimian Group AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vimian Group AB's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Vimian Group AB's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Vimian Group AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Vimian Group AB's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	45.969	/	392.461
	=	11.71 %

Vimian Group AB's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	19.581	/	109.843
	=	17.83 %

Vimian Group AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Vimian Group AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vimian Group AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vimian Group AB (OTCPK:VIMGF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

VIMIAN:Sweden 0V0:Germany

Address

Riddargatan 19, Stockholm, SWE, SE-11457

Website

https://www.vimian.com

Vimian Group AB specializes in the areas of animal health such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription and non-prescription treatments for preventive care, and treatment of chronic conditions for companion animals, with a strong position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.